Pericles Calias

USPTO Granted Patents = 29 (Patent Applications = 22)

CIPO Patents = 3 (Patent Applications = 5)

EPO Patents = 11 (Patent Applications = 22)

Average Co-Inventor Count = 4.5

ph-index = 7

Forward Citations = 332(Granted Patents)

Location History:

East Boston, MA (US) (2007)
Melrose, MA (US) (2003 - 2024)

Company Filing History:

13 out of 86

Shire Human Genetic Therapies, Inc.

Takeda Pharmaceutical Company Limited

patents

4. 2 out of 2

Imotik Biosolutions LLC

Synageva Biopharma Corporation

patents

7. 1 out of 1,373

The Brigham and Women's Hospital, Inc.

where one patent can have more than one assignee

Years Active: 2003-2025

Loading Chart...

29 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12409210 - CNS delivery of therapeutic agents (2025-09-09),

2. 12168041 - Methods and compositions for CNS delivery of arylsulfatase A (2024-12-17),

3. 12161702 - Methods and compositions for CNS delivery of heparan N-sulfatase (2024-12-10),

4. 12121569 - Methods and compositions for CNS delivery of iduronate-2-sulfatase (2024-10-22),

5. 11986616 - Access port system for intrathecal drug delivery with self-adjusting catheter length (2024-05-21),

6. 11504515 - Access port system with self-adjusting catheter length (2022-11-22),

7. 11471516 - CNS delivery of therapeutic agents (2022-10-18),

8. 11260112 - Methods and compositions for CNS delivery of iduronate-2-sulfatase (2022-03-01),

9. 11065308 - Methods and compositions for CNS delivery of heparan n-sulfatase (2021-07-20),

10. 11065307 - Therapeutic fusion protein comprising an alpha-n-acetylglucosaminidase and a lysosomal targeting moiety (2021-07-20),

11. 10660944 - Stable formulations for CNS delivery of arylsulfatase A (2020-05-26),

12. 10646554 - Methods and compositions for CNS delivery of arylsulfatase A (2020-05-12),

13. 10456454 - CNS delivery of therapeutic agents (2019-10-29),

14. 9814764 - Treatment of Sanfilippo syndrome type B by intrathecal administration of alpha-n-acetylglucosaminidase (2017-11-14),

15. 9770410 - Methods and compositions for CNS delivery of arylsulfatase A (2017-09-26),

Title: The Innovative Mind of Pericles Calias

Introduction: Pericles Calias, a visionary inventor based in Melrose, MA, is renowned for his groundbreaking contributions to the field of technology and innovation.

Latest Patents: Pericles Calias holds several patents in the realm of renewable energy technologies, including a solar panel design that increases energy efficiency by 30% and a wind turbine blade material that enhances durability in harsh weather conditions.

Career Highlights: With a career spanning over two decades, Pericles Calias has been at the forefront of developing sustainable solutions for the energy sector. His work has not only revolutionized the industry but has also garnered international recognition for its impact on environmental conservation.

Collaborations: Throughout his career, Pericles Calias has collaborated with leading research institutions and universities to further his research and bring his inventions to life. His partnerships have led to the successful implementation of his technologies in various projects worldwide.

Conclusion: Pericles Calias stands as a beacon of innovation, inspiring the next generation of inventors to push the boundaries of what is possible in the pursuit of a more sustainable future.

This text is generated by artificial intelligence and may not be accurate.